Imaging & Diagnostics

How Will the EU Secure Its Medical Radioisotope Supply?
Imaging & Diagnostics How Will the EU Secure Its Medical Radioisotope Supply?

Every single day, thousands of patients in European hospitals wait for treatments that depend on a specialized class of radioactive atoms, many of which lose their potency within hours of being produced. The European Radioisotope Valley Initiative seeks to bridge the gap between academic research

Ultrasound Helps Identify Live Parasites Under the Skin
Imaging & Diagnostics Ultrasound Helps Identify Live Parasites Under the Skin

Medical professionals in temperate climates increasingly rely on non-invasive imaging protocols to manage tropical diseases brought home by international travelers. As global connectivity expands, conditions once localized to specific equatorial regions now frequently appear in urban clinical

Why Does the Same MRI Cost More at a Hospital?
Imaging & Diagnostics Why Does the Same MRI Cost More at a Hospital?

Medicare’s Procedure Price Lookup tool often fails to show the full cost difference because it compares hospitals to surgical centers instead of freestanding imaging offices. This discrepancy often leaves patients blindsided by bills that are significantly higher than expected for routine

Is PET-CT the New Gold Standard for Australian Vet Care?
Imaging & Diagnostics Is PET-CT the New Gold Standard for Australian Vet Care?

A/Prof Zuber’s vision for veterinary medicine involves expanding PET-CT services nationally to make metabolic imaging the standard first step in cancer investigation. The establishment of PET Theranostics in Sydney represents a fundamental turning point for animal healthcare across the continent.

How Will Bexlutry Change the Treatment of GEP-NETs?
Imaging & Diagnostics How Will Bexlutry Change the Treatment of GEP-NETs?

Targeting somatostatin receptor-positive tumors of the foregut, midgut, and hindgut, Bexlutry utilizes lutetium-177 to deliver localized radiation directly to malignant cells. This recent approval by the U.S. Food and Drug Administration (FDA) represents a significant shift for Curium as it

UCLA Health Appoints Dr. Amir Iravani to Lead Theranostics
Imaging & Diagnostics UCLA Health Appoints Dr. Amir Iravani to Lead Theranostics

Targeted radiopharmaceutical therapies ensure that radioactive agents are delivered directly to malignant cells while minimizing collateral damage to healthy tissue. The appointment of Dr. Amir Iravani as the Director of the Theranostics Program and Vice Chair of Clinical Research at UCLA Health

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later